TASK THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 18 Aug 2021)
What this means for you
This application is over — abandoned 04 Aug 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90185610
- Mark type
- Stylized text
- Filed
- 16 Sept 2020
- Abandoned
- 04 Aug 2021
- Attorney of record
- Jennifer C. Debrow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer; biochemical and biopharmaceutical preparations for the treatment of cancer; gene therapy products, namely, genetically engineered materials for the treatment of cancer; cells for medical or clinical use; preparations for genetically modifying human and animal cells for diagnostic and medical purposes; preparations of blood or cells extracted from humans or animals which have been adapted for therapeutic purposes
- Class 042 — Scientific and technological services: Medical research
- Class 044 — Medical, beauty and agricultural services: Cell therapy services; gene therapy services
Owner
- ZIOPHARM Oncology, Inc, Boston, MA, US
Prosecution history
- 18 Aug 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 18 Aug 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 03 Feb 2021 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 03 Feb 2021 — PRIORITY ACTION E-MAILED
- 03 Feb 2021 — PRIORITY ACTION WRITTEN
- 28 Jan 2021 — ASSIGNED TO EXAMINER
- 23 Oct 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Sept 2020 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 21 Sept 2020 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 19 Sept 2020 — NEW APPLICATION ENTERED